21 May 2009
Liver transplantation in children with biliary atresia and polysplenia syndrome
D Broniszczak, A Apanasiewicz, H Ismail, A Chyżyńska, P Czubkowski, P KalicińskiAnn Transplant 2009; 14(1): 28-28 :: ID: 880298
Abstract
Background: Children with biliary atresia (BA) and polysplenia syndrome (PS)
have always been considered as a high risk liver transplant recipients due to
technical problems during transplant surgery. We report a single-centre experience with the liver transplantation in children with this syndrome.
Material/Methods: Between 2000 and 2008 330 liver transplants were performed in our centre in children, among them there were five with end stage liver insufficiency, with BA and PS, following the Kasai procedure. They underwent liver transplantation from living (4 patients) and deceased donors
(1 patient). All patients demonstrated additional malformations like: absence of retrohepatic vena cava (1), intestinal malrotation (2), preduodenal portal vein (1), hepatic artery (2) and cardiac anomalies (2). No situs inversus occurred. Transplantations were performed at the age ranging from 8 months to 11 years. We did not meet serious technical problems during operation, as well as never had to use vascular conduits for graft revascularization.
Results: All patents are alive and well with follow up between 9 and 105 months after transplantation, although one is with persistent hepatitis C and one has symptoms of portal hypertension after portal thrombosis which occurred during PTLD treatment one year after transplantation.
Conclusions: Results of liver transplantation in children with BA and PS syndrome are as good as for other indications for non-syndromic BA in experienced paediatric liver transplant centre.
Keywords: Liver Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860